Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07413666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 11 words
    • Secondary endpoints: details revised at 2 of 10 entries
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Trial Details
NCT Number NCT07413666
Lead Sponsor Centessa Pharmaceuticals (UK) Limited
Conditions
(from sponsor)		 Healthy Adult Male and Female Volunteers
Enrollment 212 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov